Investing.com - Financial Markets Worldwide

Magle Chemoswed Holding Ab (MAGLE)

Stockholm
Currency in SEK
20.00
+1.00(+5.26%)
Closed·
MAGLE Scorecard
Full Analysis
Operates with a significant debt burden
Unusual trading volume
Trading near 52-week Low
MAGLE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
18.5020.00
52 wk Range
18.5041.60
Key Statistics
Edit
Prev. Close
19
Open
19.1
Day's Range
18.5-20
52 wk Range
18.5-41.6
Volume
4.01K
Average Volume (3m)
1.94K
1-Year Change
-50.25%
Book Value / Share
25.8
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MAGLE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 10
Impressive gross profit margins
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Magle Chemoswed Holding Ab Company Profile

Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson’s disease. The company also offers EmboCept S, a microsphere-based medical device used in vascular occlusion of liver and lung tumors; SmartGel, a non-allergenic hydrogel based on the company’s microsphere technology; and SmartPAN, a medical device for the detection of pancreatic fluid leakage during open or minimally invasive surgical procedures. In addition, it is developing EmboCept M for the treatment of benign prostatic hyperplasia; EmboCept L for the treatment of uterine fibroids; SmartGel II, an advanced wound care hydrogel for the removal and prevention of wound biofilm; and SmartBone, an advanced formulation of microspheres in combination with active ingredients for stimulation of bone growth in surgical implant procedures. The company was founded in 1944 and is based in Malmö, Sweden. Magle Chemoswed Holding AB (publ) is a subsidiary of Magle AB.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
158
Market
Sweden

Compare MAGLE to Peers and Sector

Metrics to compare
MAGLE
Peers
Sector
Relationship
P/E Ratio
−20.4x−9.2x−0.5x
PEG Ratio
0.08−0.190.00
Price/Book
0.8x6.0x2.6x
Price / LTM Sales
1.4x5.2x3.3x
Upside (Analyst Target)
100.0%4.6%43.4%
Fair Value Upside
Unlock6.0%7.1%Unlock

Earnings

Latest Release
Aug 01, 2025
EPS / Forecast
0.10 / 0.50
Revenue / Forecast
85.30M / 87.60M
EPS Revisions
a
a
Unlock
Last 90 days

MAGLE Income Statement

FAQ

What Stock Exchange Does Magle Chemoswed Trade On?

Magle Chemoswed is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Magle Chemoswed?

The stock symbol for Magle Chemoswed is "MAGLE."

What Is the Magle Chemoswed Market Cap?

As of today, Magle Chemoswed market cap is 410.32M.

What Is Magle Chemoswed's Earnings Per Share (TTM)?

The Magle Chemoswed EPS (TTM) is -1.14.

When Is the Next Magle Chemoswed Earnings Date?

Magle Chemoswed will release its next earnings report on 30 Oct 2025.

From a Technical Analysis Perspective, Is MAGLE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Magle Chemoswed Stock Split?

Magle Chemoswed has split 1 times.

How Many Employees Does Magle Chemoswed Have?

Magle Chemoswed has 158 employees.

What is the current trading status of Magle Chemoswed (MAGLE)?

As of 10 Aug 2025, Magle Chemoswed (MAGLE) is trading at a price of 20.00, with a previous close of 19.00. The stock has fluctuated within a day range of 18.50 to 20.00, while its 52-week range spans from 18.50 to 41.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.